Latest Prophylaxis Stories
A new study shows that pre-exposure preventative treatment for suspected HIV may be effective for those in high-risk groups.
While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups.
A Rush University Medical Center led international research team has announced that a treatment to prevent bleeding episodes in children with hemophilia A also is effective for adolescents and adults.
In sub-Saharan Africa, couples in long-term relationships where one partner is HIV-positive and the other is HIV-negative (HIV serodiscordant couples) could benefit from anti-AIDS drugs (antiretroviral therapy) given either as treatment or as a prevention measure (prophylaxis) to reduce the risk of HIV transmission.
Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy.
The first human studies of an oral drug regimen to prevent HIV infection in high-risk individuals yielded a promising near 50% reduction in HIV incidence, but a number of issues require additional research before oral pre-exposure prophylaxis (PrEP) can be implemented on a large scale.
SEATTLE, Nov. 23, 2010 /PRNewswire/ -- Congratulations to the investigators and staff who conducted iPrEx, a rigorous trial of HIV prevention by administration of daily anti-retroviral medicine to men at high risk of HIV infection.
CHICAGO, Nov. 2, 2010 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc.
NEW YORK, July 6, 2010 /PRNewswire/ -- The Steering Committee of the EXCLAIM study that explored the benefit of extended prophylaxis of venous thrombo embolism (VTE) with enoxaparin in acutely ill medical patients, announced today the publication of the comprehensive study results in the peer-reviewed journal Annals of Internal Medicine. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/prne/exclaim/44182/ The study showed that in recently...